Manipulation of immunodominance to promote heterosubtypic immunity to Influenza

操纵免疫优势促进流感异亚型免疫

• 批准号: 7088281
• 负责人: Andrea Janine Sant
• 金额: $ 23.4万
• 依托单位: UNIVERSITY OF ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-04-15 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7088281
• 关键词: human; immunity; influenza; peptides

DESCRIPTION (provided by applicant): The major goal of the experiments outlined in this R21 proposal is to promote heterosubtypic immunity to influenza virus infection. Influenza is a significant human pathogen for which there is no available vaccine1 that promotes persistent and effective immunity. This is a particularly urgent objective of late because of the emergence of a highly pathogenic H5N1 strain of avian influenza that has passed to humans, creating a potential threat of a pandemic. Recently, our laboratory has developed a novel and successful strategy to manipulate immunodominance in CD4 T cell responses. In this proposal, we wish to use this strategy to explore whether intentional focus of the CD4 T cell response toward epitopes shared among subtypes of influenza, particularly those expressed within the H5 subtype, will promote protective heterosubtypic immunity. Because of the direct implication of these studies on human vaccine design, we will perform these experiments using peptides presented by human HLA-DR molecules and DR1-transgenic mice. We will derive novel HA peptide-containing protein constructs to drive intentional focus of the CD4 T cell response towards hemagglutinin epitopes that are highly conserved among serologically distinct HA subtypes. Specific Aim 1: Identification of immunodominant DR1-restricted CD4 T cell epitopes to influenza HA. Specific Aim 2: Design and utilize kinetic stability variants of HA-derived peptides to promote immunodominance. Specific Aim 3. Promoting focus of the CD4 T cell responses toward conserved epitopes and protection to virus challenge.

描述（由申请方提供）：本R21提案中概述的实验的主要目标是促进对流感病毒感染的异亚型免疫。流感是一种重要的人类病原体，目前尚无可促进持久有效免疫的疫苗1。这是最近一个特别紧迫的目标，因为出现了一种高致病性H5 N1禽流感毒株，该毒株已传染给人类，造成了大流行病的潜在威胁。最近，我们的实验室已经开发出一种新的和成功的策略来操纵CD 4 T细胞反应中的免疫优势。在这个提议中，我们希望使用这种策略来探索是否有意将CD 4 T细胞应答集中在流感亚型之间共享的表位上，特别是那些在H5亚型内表达的表位，将促进保护性异亚型免疫。由于这些研究对人类疫苗设计的直接影响，我们将使用人类HLA-DR分子和DR 1转基因小鼠呈递的肽进行这些实验。我们将获得新的HA肽含有蛋白质的结构，以驱动CD 4 T细胞反应的故意集中对血凝素表位之间的血清学不同的HA亚型高度保守。具体目的1：鉴定流感HA的免疫显性DR 1限制性CD 4 T细胞表位。具体目标2：设计和利用HA衍生肽的动力学稳定性变体以促进免疫优势。具体目标3。促进CD 4 T细胞对保守表位的反应集中和对病毒攻击的保护。